The pathogenesis of hepatocellular carcinoma (HCC) involves many molecular pathways. Glycine N-methyltransferase (GNMT) is downregulated in almost all HCC and its gene knockout mice developed HCC with high penetrance. We identified PREX2, a novel PTEN inhibitor, as a GNMT-interacting protein. Such interaction enhanced degradation of PREX2 through an E3 ligase HectH9-mediated proteasomal ubiquitination pathway. Depletion of GNMT or HectH9 resulted in AKT activation in a PREX2 dependent manner and enhanced cell proliferation. An elevated PREX2 protein expression accompanied by activation of AKT was observed in the liver of Gnmt knockout mice. PREX2 protein expression was upregulated in 54.9% of human HCC samples, while its mRNA level was comparable in tumor and tumor-adjacent tissue, suggesting a post-translational alteration of PREX2 expression. Higher level of PREX2 in the tumor tissues was associated with poorer survival. These results reveal a novel mechanism in which GNMT participates in AKT signaling and HCC tumorigenesis by promoting HectH9-mediated PREX2 degradation.
Introduction
The tumor suppressor gene PTEN (phosphatase and tensin homolog on chromosome 10) encodes a lipid phosphatase that dephosphorylates phosphatidylinositol 3,4,5-trisphosphate (PIP3), which is generated by phosphoinositide 3-kinase (PI3K) upon stimulation of cells by external mitogens. 1 Inactivation of PTEN leads to hyper activation of PI3K-AKT signaling, which promotes cell proliferation and survival, thereby contributing to tumorigenesis. Mutation of PTEN has been reported in 70% of glioblastoma, 50% of endometrial carcinoma and 50% of prostate carcinoma. 2 While a low frequency of genetic alteration of the PTEN-PI3K-AKT pathway in HCC has been reported, 3 abnormal activation of the PI3K-AKT-mTOR sig-in HCC is not fully understood. DEP domain-containing 2 (DEPDC2, also named PREX2) is a novel PI3K sensitive Rac exchange factor which serves as an activator of Rac signaling in response to both PIP3 and the beta-gamma subunits of G proteins. 6, 7 PREX2 is an inhibitor of PTEN protein and regulates the PI3K-AKT signaling cascade. 8, 9 Moreover, PREX2 is overexpressed in various tumors, including breast, prostatic, ovarian and pancreatic cancers as well as glioma. 8, 10 Its regulatory mechanisms still remain to be elucidated.
GNMT, a key player in the one-carbon metabolism pathway, 11 is frequently downregulated in human HCC, 12, 13 and Gnmt knockout mice developed HCC. 14 GNMT has been proposed to be an example of a moonlighting protein. 15 GNMT is able to switch its function from acting as a metabolic enzyme to being a 4S PAH binding protein based on its phosphorylation state, which changes the subunit configuration. [16] [17] [18] [19] By changing the cellular localization of GNMT from the cytoplasm to the nucleus, GNMT is able to act as a transcription cofactor and regulate the expression of detoxification (and/or other target) genes. 18, 20 Moreover, by changing its binding partners, GNMT is involved in cellular signaling cascades such as the mTOR pathway and in other cellular processes involved in cholesterol homeostasis and cell cycle control. 21, 22 Here we identified PREX2 as a novel GNMTinteracting protein and homologous to E6AP carboxyl terminus homologous protein 9 (HectH9) as an E3 ligase for PREX2. We present a molecular mechanism in which GNMT exerts its tumor suppressive effect by promoting HectH9-mediated PREX2 ubiquitination and degradation.
Materials and Methods

Hepatocellular carcinoma (HCC) patients
All the HCC specimens were obtained from the Taiwan Liver Cancer Network (TLCN). The specimens were obtained during surgery, and thus the pathological stage for each case was known. For analysis of protein expression, 51 pairs (mean age, 59.5 6 14.2) of tumor and tumor-adjacent (TA) tissues from HCC patients were used. We divided them into 3 groups according to type of hepatitis infection: 17 patients (7 males and 10 females) were HBsAg-positive, 18 patients (10 males and 8 females) were anti-HCV Ab-positive, and 16 patients (9 males and 7 females) did not have hepatitis B or C. For analysis of mRNA expression, in addition to the 51 pairs mentioned above, 88 extra pairs were included. These 139 pairs (mean age, 59.65 6 13.4) of tumor and TA tissues from HCC patients, included 59 patients (44 males and 15 females) who were HBsAg-positive, 61 patients (40 males and 21 females) who were anti-HCV Ab-positive, and 19 patients (10 males and 9 females) who did not have hepatitis B or C. Informed consent was obtained from all the patients before they received surgery. In addition, clinical and pathological data including numbers of HCC nodules, tumor size, vascular invasion of tumor cells, and duration of survival were provided by TLCN. Our study was approved by the Institutional Review Board of Kaohsiung Medical University and the user committee of TLCN.
Plasmids and constructs
pGNMT-Flag, 23 pGEX-GNMT 13 and the lentiviral expression constructs, including pLV-GNMT-FLAG 22 construct have been described previously. The domains of PREX2 were cloned into the pcDNA3 vector (Thermo Fisher Scientific, Waltham, MA) using Myc-PREX2 as a template. The PDZ domains of PREX2 were cloned into the pET28a vector (Novagen, Inc., Madison, WI,) using Myc-PREX2 as a template. To generate the lentiviral expression construct for GNMT, the coding sequences for Flag-tagged GNMT were inserted into the lentiviral vector pLKO-AS3w.hyg (National RNAi Core Facility, Academia Sinica, Taipei, Taiwan). Two mission lentiviral shRNA vectors targeting HectH9: HectH9-lentiviral shRNA-1 (5 0 CCACACTTTCACAGATACTAT3 0 ) and HectH9-lentiviral shRNA-2 (5 0 GCTCCCACTATAACCTCAC TT3 0 ) have been described previously. 24 Two plasmids encoding different shRNAs for PREX2: PREX2-lentiviral shRNA-1 (5 0 CGAATTTGTGTCATGGCTGTT3 0 ) and PREX2-lentiviral shRNA-2 (5 0 GAACAGGGTGAGAAACTTTAT3 0 ), two mission lentiviral shRNA vectors targeting GNMT: GNMT-lentiviral shRNA-1 (5 0 CATTCCCTGCTACTTCATCCA3 0 ) and GNMTlentiviral shRNA-2 (5 0 CCTACATTCCCTGCTACTTCA3 0 ), the control plasmids for the RNA interference (pLKO.1-shLacZ) and for the overexpression experiments (pLKO-AS3w.eGFP.puro and pLKO-AS3w.eGFP.hyg), the packaging plasmid (pCMV-DR8.91) and the envelope plasmid (pMD.G) were obtained from National RNAi Core Facility (Academia Sinica, Taiwan). Myc-PREX2 construct was obtained from Dr. H. C. E. Welch. HA-ubiquitin was a gift from Dr. P. H. Tseng. Flag-Smurf1 was gifted from Dr. J. L. Wrana. HA-cbl-a and HA-cbl-c were obtained from Dr. S. Lipkowitz. HA-Nedd4 was obtained from Dr. P. P. Pandolfi.
What's new? Hepatocellular carcinoma (HCC) is associated with various molecular anomalies, including downregulation of glycine N-methyltransferase (GNMT), an enzyme with metabolic functions in the liver. Our study sheds light on the enigmatic role of GNMT deficiency in liver tumorigenesis, showing that GNMT interacts with PREX2, an oncogenic regulator of PTEN/PI3K/AKT signaling. In cell and animal models, GNMT interaction enhanced HectH9-mediated PREX2 degradation, while its depletion was associated with elevated post-translational PREX2 expression. Increased PREX2 was further linked to poor survival in HCC patients. Hence, GNMT downregulation appears to contribute to HCC via reduced PREX2 ubiquitination, consequent AKT signaling and dysregulated cell proliferation.
(His) 6 -ubiquitin, Flag-TRAF6, Flag-Smurf2, Flag-FBW7, Flag-c-IAP1, Flag-c-IAP2, Myc-ITCH, HA-Cbl-b and HA-HectH9 have been described previously. 25 Flag-RNF8 and HA-RNF2 constructs 26 and Xp-Skp2 construct 24 were described previously.
Cell cultures and transfection
HEK293T, HuH-7, HepG2, Mahlavu, SK-Hep-1, PLC and HA-22T cells were cultured in complete Dulbecco's modified Eagle's medium (DMEM). DMEM contained 10% heat-inactivated fetal bovine serum (FBS), penicillin (100 U/ml), streptomycin (100 lg/ml), nonessential amino acids (0.1 mM) and Lglutamine (2 mM) (Thermo Fisher Scientific, Waltham, MA). Lentivirus-infected cells were grown in complete DMEM supplemented with either puromycin (1 lg/ml, Sigma-Aldrich, St. Louis, MO) alone or puromycin (1 lg/ml) and hygromycin (100 lg/ml, Thermo Fisher Scientific) together. Plasmid DNA was transfected by using TurboFect TM Reagent (Fermentas, Hanover, MD). All transfections were performed according to the manufacturers' instructions.
Antibodies
A rabbit polyclonal antibody (Ab) to recombinant protein of DH-PH domains of PREX2 was raised and purified as described previously. 13 The following Ab were used at dilutions recommended by manufacturers: anti-GNMT Ab (YMAC Biotech Co, Taipei, Taiwan), anti-PREX2 Ab (Sigma), antiHectH9 Ab (Abcam, Cambridge, MA) (Bethyl Laboratories, Montgomery, TX), anti-ubiquitin, K48-specific Ab (Millipore, Bedford, MA), anti-total ATK Ab, anti-phospho-AKT (S473) Ab, anti-phospho-AKT (T308) Ab, anti-phospho-Foxo1 (T24)/ Foxo3a (T32) antibody, anti-phospho-GSK3b (S9) antibody (Cell Signaling Technology, Beverly, MA), anti-PTEN Ab (Millipore), anti-Myc Ab, anti-Xpress Ab (Thermo Fisher Scientific), anti-HA Ab (Covance, Berkeley, CA), anti-FLAG Ab, anti-b-actin Ab and anti-GAPDH Ab (Sigma).
Viral infection
For lentivirus preparation, HEK293T cells were cotransfected with a packaging plasmid-pCMV-DR8.91, a VSV-G envelope expressing plasmid-pMD.G and the lentiviral constructs by using TurboFect TM Reagent (Fermentas). Supernatant containing lentiviruses were harvested according to the protocol published on the web site (http://rnai.genmed.sinica.edu.tw/). To generate stable cell lines, cells were infected with pseudotyped lentivirus in medium containing polybrene (8 lg/ml). Antibiotics were added to the media 48 hr after infection to select stable cells.
Immunoprecipitation and immunoblotting
Immunoprecipitation (IP) and immunoblotting (IB) were performed essentially as described previously with some modifications. 22, 24 In brief, mouse liver or cultured cells were lysed by E1A lysis buffer (250 mM NaCl, 50 mM HEPES (pH 7.5), 0.1% NP40 and 5 mM EDTA) supplemented with protease inhibitor cocktail (Roche, Mannheim, Germany) and phosphatase inhibitors (1 mM NaF, 5 mM NaPPi and 10 mM Na 3 VO 4 ). The concentrations of the cell lysates were measured using Bio-Rad protein assay (Bio-Rad, Hercules, MA). The lysates were incubated with antibodies either overnight or 4 hr at 48C and followed by incubation with protein-A/G sepharose (GE Healthcare, Pittsburgh, PA) for 2 hr. For sequential co-IP, HEK293 T cells were transfected with the indicated plasmids, treated with 10 lM MG132 for 8 hr and harvested using E1A buffer. The cell lysates were incubated with anti-Myc Ab for 4 hr at 48C and followed by addition of protein-A/G sepharose for 2 hr. The anti-Myc immunoprecipitates were eluted by incubation with c-Myc peptide (200 lg/ml, Sigma) overnight at 48C and then subjected to an anti-HA IP. After precipitation, the beads were washed with lysis buffer and eluted in sample buffers for SDS-PAGE and immunoblotting analyses.
In vitro immunoprecipitation assays
Expression and purification of recombinant proteins were performed as described previously with some modifications. 13 In brief, both of the GST-tagged GNMT (GST-GNMT) and the His-and Myc-double tagged tandem PDZ domains of PREX2 (His-Myc-2XPDZ) recombinant proteins were induced in BL21 cells using IPTG. GST-GNMT recombinant protein was purified using Glutathione Sepharose 4 Fast Flow according to the manufacturer's instructions (GE Healthcare) and eluted by incubation with glutathione. His-Myc-2XPDZ recombinant protein was purified using Ni-NTA agarose as recommended by the manufacturer (Thermo Fisher Scientific) and eluted by addition of imidazole. The concentrations of the recombinant protein were measured using Bio-Rad protein assay (Bio-Rad). The purified GST-GNMT was incubated with His-Myc-2XPDZ for 4 hr at 48C in the E1A buffer, followed by incubation with anti-Myc Ab for 4 hr at 48C and incubated with protein A/G beads for 2 hr. The beads were washed with E1A buffer and eluted in sample buffers for SDS-PAGE and immunoblotting analyses.
Pulse-chase and cycloheximide analysis
For pulse-chase analysis, Huh7 cells were co-transfected with the indicated plasmids for 48 hr and pre-incubated with methionine/cysteine-free DMEM containing 10% dialyzed fetal calf serum for 40 min at 378C. Labeling was performed for 30 min at 378C with 0.3 mCi/ml 35 S-labeled cysteine and methionine (PerkinElmer, Shelton, CT). After labeling, chase medium (complete DMEM containing 15 lg/ml methionine and cysteine) was added and incubated for the indicated hours. The concentrations of cell lysate were quantified, antiMyc Ab was added and incubated with protein A/G. The beads were washed with Radio-immunoprecipitation assay (RIPA) buffer and subjected to SDS-PAGE, followed by autoradiography. For cycloheximide (CHX) treatment, Huh7-stable cells were treated with CHX (70 lg/ml, Sigma) for the indicated hours, harvested and subjected to SDS-PAGE and immunoblotting analyses. Densitometry was performed using Dolphin View Band Tool (Wealtec Corp., Sparks, NV).
In vivo ubiquitination assay
In vivo ubiquitination assay was performed as described elsewhere. 25 In brief, HEK293T cells were transfected with the indicated plasmids for 36-48 hr, treated with 10 lM MG132 (Calbiochem, Darmstadt, Germany) for 4 hr and lysed with denaturing buffer (6 M guanidine-HCl, 0.1 M Na 2 HPO 4 / NaH 2 PO 4 , 10 mM imidazole) or E1A buffer. For cell extracts prepared by denaturing buffer, the cell extracts were then incubated with Ni-NTA agarose for 3 hr, washed, and subjected to immunoblotting analyses. For cell extracts prepared by E1A buffer, IP was performed with either anti-Myc Ab or anti-PREX2 Ab as described above. The precipitants were then subjected to immunoblotting analyses.
Cell proliferation assay
Cells were seeded in a 96-well plate (1,000 cells per well) in at least triplicate for each experiment. At the indicated time point, alamarBlue V R (10%, Thermo Fisher Scientific) was added and further incubated for 4 hr at 378C. Fluorescence of the reduced alamarBlue V R was measured by microplate reader (Synergy HT, BioTek Instruments, Winooski, VA). The amount of fluorescence for each group was normalized to the next day of seeding (day1) and shown as fold increase. All data are presented as mean 6 SE.
Colony formation assay
Cells were seeded in six-well plates (3,000 cells per well). After 2 weeks, colonies were stained with 0.05% crystal violet in 10% formalin, and the number and area of colonies were analyzed by CellProfiler. 27 In vivo tumorigenesis assay Huh7 stable cells (2x10 6 ) mixed with matrigel (1:1) were subcutaneously injected into the right flank of 6-week-old female NOD/SCID mice (n 5 5/group). Tumor size was measured 3 times a week using a caliper, and tumor volume was determined by using the standard formula: L 3 W 2 3 0.5, where L is the longest diameter and W is the shortest diameter. Data are presented as mean of tumor volume 6 SEM. The protocol was reviewed and approved by the Institutional Animal Care and Use Committee of Kaohsiung Medical University in compliance to the guidelines on the care and use of animals for scientific purposes.
Tissue extracts
Tissues were lysed with RIPA lysis buffer (50 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 0.25% sodium deoxycholate, 1% Nonidet P-40 and protease inhibitor cocktail (Sigma)) and homogenized by a tissue lyser (Qiagen, Valencia CA). The concentrations of tissue extracts were measured using Bio-Rad protein assay (Bio-Rad) and they were then subjected to SDS-PAGE and immunoblotting analyses.
Immunohistochemical (IHC) staining
Detailed procedures for IHC staining have been described previously. 13 Mouse monoclonal antibodies against Ki-67 (BD biosciences, SanJose, CA) were used. Signals were visualized using SuperPicTure TM Polymer Detection kits (Zymed/ Invitrogen, Carlsbad, CA). The intensity of staining was evaluated by ImageJ software (NIH, Maryland, USA).
Reverse transcription and real-time PCR
Reverse transcription and real-time PCR were carried out as previously described. 28 The primers used for the real-time PCR were listed in Supporting Information Table 1 . Predicted cycle threshold (CT) values were exported into EXCEL worksheets for analysis. Comparative CT methods were used to determine fold difference in gene expression relative to TBP or Actin.
Statistical analysis
Statistical analysis was performed using SPSS software (version 13, SPSS, Inc., Chicago, IL, USA) and p < 0.05 was considered to be statistically significant. Pearson v 2 or Fisher's exact tests were used to evaluate the association between PREX2 expression and different clinicopathological characteristics of HCC patients. Multivariate logistic regression models were used to adjust for covariate effects on the odds ratio (OR). Comparisons between groups were made using the one-way ANOVA (with Duncan's multiple range test for post hoc comparison) and Student's t-test. The Kaplan-Meier estimation method was used for overall survival analysis, and a log-rank test was used to compare differences. Multivariate survival analyses were conducted using a Cox proportional hazards regression model.
Results
Identification of PREX2 as a novel GNMT-interacting protein
We previously reported that GNMT escapes its original role as an enzyme and interacts with DEPTOR. 22 We postulated that other proteins containing domain architecture similar to DEP-TOR may interact with GNMT. We then performed a similarity search with a conserved domain architecture retrieval tool (http://www.ncbi.nlm.nih.gov/Structure/lexington/lexington. cgi?). 29 The domain structure of DEPTOR looked like a truncated version of PREX2 (Fig. 1a) . GNMT bound to the PDZ domain of DEPTOR, 22 so we then tested whether GNMT also interacted with PREX2. To confirm the interaction of GNMT and PREX2, co-immunoprecipitation (co-IP) assays were performed using cell lysates from HEK293T cells co-expressing PREX2 and GNMT. Reciprocal co-IP assays showed that GNMT coimmunoprecipitated with PREX2 (Figs. 1b and 1c) . Since GNMT is down regulated in HCC cell lines, we used cell lysate from Huh7 cells stably expressing Flag-tagged GNMT 22 and found that Flag-tagged GNMT interacted with endogenous PREX2 in Huh7 cells (Fig. 1d) . The endogenous interaction of GNMT and PREX2 was demonstrated by reciprocal co-IP assays that were performed using normal mouse liver lysates (Fig. 1e) . To map the binding domain, different Myc-tagged PREX2 truncated mutants were co-expressed with Flag-tagged GNMT in HEK293T cells and we found that the paired PDZ domain mediated its interaction with GNMT (Fig. 1i) . Furthermore, the direct binding of GNMT and the paired PDZ domain (2XPDZ) was demonstrated by in vitro IP assay using purified GST-GNMT and His-Myc-2XPDZ recombinant proteins (Fig. 1g) .
GNMT negatively regulates PREX2-mediated AKT signaling
Interestingly, we noticed that the expression of endogenous PREX2 was significantly reduced in HepG2 cells overexpressing GNMT and this effect was reversed by treatment with the proteasome inhibitor MG132 (Fig. 2a) . Furthermore, pulse-chase experiments revealed that overexpression of GNMT remarkably shortened the half-life of PREX2 from 11.24 hr to 7.73 hr in Huh7 cells (Fig. 2b) . Since the Lys (K) 48-linked poly-ubiquitin chain on the target protein is the major signal of proteasomal degradation, 30 we investigated whether GNMT promotes K48-linked ubiquitination formation on the PREX2 protein.
Indeed, GNMT overexpression promoted K48-linked ubiquitination of PREX2 in MG132 treated cells (Fig. 2c) . Because PREX2 is a component of the PI3K-AKT pathway, 8 we next determined the effects of this interaction on the PI3K-AKT cascade. Knockdown of GNMT in Huh7 cells resulted in substantial increase in the PREX2 protein while it did not affect PREX2 mRNA levels (Fig. 2d, and Supporting Information Fig. 1) . Moreover, subsequent increases in phosphorylation of AKT at Thr308 and Ser473 and gain of growth ability were found in GNMT knockdown cells (Figs. 2d and 2e ). This increased AKT phosphorylation correlated with the elevated phosphorylation level of glycogen synthase kinase 3 (GSK3b) (Fig. 2d) , a known AKT substrate. 31, 32 Furthermore, the increase in AKT phosphorylation was PREX2-dependent, as depletion of both GNMT and PREX2 expression reversed AKT activation (Supporting Information Fig. 2 and Fig. 1f) . Activation of AKT also suppresses apoptosis. In agreement with this notion, we found that overexpression of PREX2 significantly reduced caspase 3/7 activity, and this reduction was neutralized by overexpression of GNMT (Supporting Information Fig. 3 ). Moreover, depletion of GNMT in PTEN-knockdown or PTEN-deficient cells, while it increased PREX2 protein levels, did not further enhance the activation of AKT and growth ability (Figs. 2g-2j) . Accordingly, these findings indicated that GNMT modulates AKT phosphorylation through the PREX2-PTEN axis by negatively regulating PREX2 function through the ubiquitinproteasome pathway.
Elevated PREX2 protein level and AKT phosphorylation in Gnmt knockout mice liver JAK-STAT, Wnt and MAPK signaling pathways have been shown to be activated in Gnmt knockout mice liver due to epigenetic or transcriptional alterations.
14, 33 Here, we found that depletion of GNMT in HCC cells resulted in PREX2 accumulation and AKT activation. We then explored the effect of GNMT on PREX2 and AKT in vivo in Gnmt knockout mice liver. A significantly elevated protein level of PREX2 concomitant with increased phosphorylation of AKT on Ser473 was observed in Gnmt knockout mice liver (Supporting Information Figs. 4A and 4B) . Notably, a positive and statistically significant correlation was found between PREX2 protein level and AKT phosphorylation (Supporting Information Fig. 4C ). In contrast to the protein level, the mRNA of PREX2 was not affected in Gnmt knockout liver (Supporting Information Fig. 4D ). These findings further supported the notion that GNMT regulates PREX2 posttranslationally.
HectH9 interacts with PREX2, and leads to its ubiquitination and degradation
To identify the E3 ligase responsible for ubiquitin-dependent PREX2 degradation, we screened a panel of E3 ligases for PREX2 ubiquitination in the presence of MG132. The results showed that among those E3 ligases, overexpression of homologous to E6AP carboxyl terminus homologous protein 9 (HectH9; also known as Huwe1, Mule or ARF-BP1) strongly promoted PREX2 ubiquitination in vivo (Fig.3a) . HectH9 belongs to the Hect-domain family of ubiquitin ligases, which are characterized by a conserved carboxy-terminal catalytic domain. 34 Various substrates of HectH9 have been reported to be involved in apoptosis (Mcl-1) 35 and transcriptional regulation (p53, c-Myc and N-Myc). [36] [37] [38] Co-IP assay demonstrated that HectH9 interacted with the paired PDZ and InsPx4 domains of PREX2 (Fig. 3b) . We explored the effect of HectH9 on endogenous PREX2 expression in HCC cells. Compared to control, Huh7 cells infected with lentiviruses expressing shRNAs targeting HectH9 had increased levels of PREX2 proteins (Fig. 3c) . A similar effect was also observed in HepG2 cells (Fig. 3d) . Cycloheximide treatment revealed that the increase in PREX2 following HectH9 depletion was greatly due to increase in the half-life of PREX2 (Fig. 3e) . Notably, the level of endogenous K48-linked ubiquitination of PREX2 was markedly diminished upon HectH9 depletion (Fig. 1f) .
HectH9 regulates PREX2-mediated AKT signaling, cell proliferation and HCC tumor growth
To determine the biological significance of PREX2 degradation by HectH9 in HCC cells, we knocked down HectH9 in two PTEN wild-type cell lines, Huh7 and HepG2. HectH9 suppression in Huh7 cells exhibited increased phosphorylation of AKT and the AKT substrates GSK3b, Foxo1 and Foxo3a as well as enhanced cell proliferation and colony formation (Fig. 4a-e) . Likewise, elevated cell proliferation was observed in HepG2 cells (Fig. 1f) . Moreover, the increased AKT phosphorylation and cell proliferation were dependent on PREX2 function, as suppressing both HectH9 and PREX2 expression reversed AKT activation and cell proliferation (Figs.4g and 4h) . In contrast, while Mahlavu cells, a PTENdeficient cell line (Supporting Information Fig. 5 ), also displayed an increased PREX2 expression after introduction of HectH9 shRNA, the amounts of AKT phosphorylation (Fig.  4i) and extent of proliferation (Fig. 4j) were not perturbed. This suggests that PTEN expression is required for HectH9-PREX2-mediated AKT activation and cell proliferation. To further investigate whether HectH9 regulates liver cancer development in vivo, we monitored the influence of HectH9 expression on tumor growth in a xenograft model. Consistent with the in vitro findings, HectH9 depletion largely increased the growth of xenograft tumors, while suppression of both HectH9 and PREX2 expression reversed tumor growth (Fig.  4k) . Immunohistochemical staining showed that HectH9 suppression led to upregulation of Ki-67 expression in xenograft tumors, and this effect could be rescued by further knockdown of PREX2 expression (Fig. 4l) . Thus, HectH9 regulates AKT signaling by targeting PREX2 for proteasomal degradation.
GNMT-mediated regulation of PREX2 is associated with HectH9
To explore the interaction among GNMT, PREX2 and HectH9, we performed sequential co-IP. The presence of GNMT, paired PDZ domains of PREX2 and HectH9 in the second co-IP indicated that they formed a complex (Fig. 5a ). In addition, co-IP revealed that HectH9 interacted more efficiently with PREX2 when GNMT was co-expressed (Fig. 5b) . Next, we explored the functional relevance of this interaction in HCC cells. Strikingly, depletion of HectH9 in Huh7 cells reversed GNMT-mediated downregulation of PREX2 expression (Fig. 5c) . Moreover, GNMT-induced PREX2 hyperubiquitination was suppressed after HectH9 depletion in Huh7 cells (Fig. 5d) . In agreement with our previous findings, 22 overexpression of GNMT significantly decreased Huh7 cell proliferation, and this effect was reversed after depletion of HectH9 (Fig. 5e) . Thus, the regulation of PREX2 by GNMT was associated with HectH9.
PREX2 is overexpressed in human HCC and associated with poorer survival
We next examined PREX2 and GNMT expression in tumorous (T) and tumor-adjacent (TA) tissues from HCC patients. Consistent with our previous findings, GNMT protein expression was highly suppressed in HCC tumor tissue. The protein levels of PREX2 were significantly higher in T tissues than in the corresponding TA tissues in 54.9% (28/51) of HCC patients (Figs. 6a and   6 b). In contrast, the levels of PREX2 mRNA were similar in both T and TA groups (Fig.  6c) . Similar PREX2 mRNA expression profiles were observed in another cohort consisting of 88 HCC patients (Fig. 6d) . These findings suggested that a post-translational alteration could be involved in the overexpression of PREX2 in HCC. Notably, a statistically significant negative correlation was found between GNMT and PREX2 protein levels in T and TA tissues (r 5 20.28; p 5 0.017, Fig. 6e ), which suggested an association between GNMT suppression and elevated PREX2 expression in HCC.
In addition, PREX2 overexpression was significantly correlated with the following clinical characteristics: viral infection (p 5 0.003), tumor size (p 5 0.03) and AFP levels (p 5 0.04) (Supporting Information Table 2 ). Multivariate logistic regression revealed that PREX2 expression significantly correlated with hepatitis B infection (odds ratio 5 16.06, p 5 0.009) (Supporting Information Table 3 ). The higher level of PREX2 in the T tissues was associated with poorer survival (p 5 0.02) (Fig. 1f) . Cox proportional hazards model was used to evaluate factors associated with prognosis of HCC patients, and the results showed that the association between death and PREX2 overexpression was statistically significant (hazard ratio 5 3.36, p 5 0.03) (Supporting Information Table 4 ). Collectively, the results suggest that the level of PREX2 protein expression was associated with reduced survival and may serve as a prognostic marker of survival in HCC patients.
Discussion
PREX2 is an important regulator of the PTEN-PI3K-AKT pathway. We have identified HectH9 as a novel ubiquitin E3 ligase that mediates PREX2 degradation. We found that depletion of HectH9 leads to accumulation of PREX2, which results in AKT activation and enhancement of cell proliferation. Moreover, we demonstrated that GNMT directly interacts with PREX2 and promotes the binding of PREX2 and HectH9, and thus enhances the degradation of PREX2. Therefore, we propose a model in which GNMT enhances ubiquitination and a consequent degradation of PREX2 through association with HectH9 and regulates cell proliferation in normal liver. In a GNMT-downregulated liver environment, lower association between HectH9 and PREX2 leads to reduced ubiquitination of PREX2 and a subsequent dysregulation of PREX2 expression. PREX2 overexpression results in increased AKT signaling and dysregulated cell proliferation, and promotes HCC development (Supporting Information Fig. 6 ). In addition to the effects on AKT activation, we also found that GNMT and HectH9 counteracted PREX2-induced cell migration (Supporting Information Figs. 7 and 8 ). Further studies are needed to elucidate the role of GNMT, HectH9 and PREX2 in metastasis.
HectH9 is a large, multi-domain member of the HECT domain family of E3 ubiquitin ligases. 34 However, the role of HectH9 in cancer remains controversial. The most confusing aspect of the controversy surrounding HectH9 is that both HectH9 directly binds to and ubiquitylates p53 and that depletion of HectH9 stabilizes p53. 37 By contrast, a recent study showed that HectH9 ubiquitylates N-Myc through K48-mediated linkages and decreases its expression through preteasomal degradation. 38 Moreover, Inoue et al. reported that HectH9 suppresses Ras-driven tumorigenesis by prevention of c-Myc/Miz1-mediated downregulation of p21 and p15. 39 Here, we found that depletion of HectH9 in HCC cells resulted in activated AKT signaling and increased cell proliferation through the PREX2-PTEN pathway. Furthermore, in a xenograft model, suppression of HectH9 in Huh7 cells largely increased the growth of xenograft tumors and this effect was dependent on PREX2 expression. Therefore, our results suggest a tumor suppressive function of HectH9 in HCC. Interestingly, we did not observe notable changes in HectH9 mRNA expression between HCC tumorous and tumor-adjacent tissues (Supporting Information Fig. 9 ). PREX2 has been reported to be upregulated in HCC and to play roles in the regulation of HCC cell proliferation and in CXCL9-induced HCC migration and invasion. 40, 41 In agreement with these reports, we demonstrated that PREX2 accumulation resulting from either GNMT or HectH9 depletion led to AKT activation and enhanced proliferation. Knock-down of PREX2 in Huh7 cells significantly reduced xenograft tumor growth. However, no notable alteration in PREX2 mRNA was found in our HCC specimens (139 paired T and TA specimens). The dissimilarity between the finding in our study and previous reports could be attributed to the sample size used in different studies (139 pairs in our study vs. 45 pairs in Lan's report and 15 pairs in He's report). 40, 41 In addition, viral infection could also contribute to these discrepancies. Eighty-four percent (38/45) of patients in He's study were positive for HBsAg, while only 42.4% (59/139) patients in our cohort were HBsAg positive. Among these patients, a slightly increased PREX2 mRNA level in tumorous tissue (p 5 0.08) was observed (Supporting Information Fig.  10 ). Interestingly, a significant association between PREX2 protein level and HBV infection was found in our study. Therefore, further investigation is required to delineate the interaction between HBV infection and the regulation of PREX2. Moreover, whether GNMT participates in this interaction also needs to be elucidated. Previously, Berger et al. reported non-synonymous somatic PREX2 mutations in 14% of a melanoma cohort. 42 Moreover, mutation of PREX2 has also been reported in 10% of stomach, colorectal and lung cancers. 43 It has been proposed that GNMT participates in the maintenance of genome integrity. 44 Thus, it is reasonable and worth to investigate whether the PREX2 gene in HCC also harbors somatic mutations and whether PREX2 mutants escape HectH9-mediated degradation. Nevertheless, PREX2's function can be modulated through somatic mutation. 42, 43 transcriptional alteration 8 and change in the context of protein interaction, and these different regulatory mechanisms of PREX2 could explain the weak negative correlation between GNMT and PREX2 expression levels in human HCC specimens. Therefore, further investigations on the regulatory mechanisms of PREX2 are needed and should provide new insights into tumor biology and therapeutic intervention.
